Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Österlund, C.
Right arrow Articles by Fried, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Österlund, C.
Right arrow Articles by Fried, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 6, No. 6, 498-503, June 2000
© 2000 European Society of Human Reproduction and Embryology


Ovary and oogenesis

TGFß receptor types I and II and the substrate proteins Smad 2 and 3 are present in human oocytes

Christina Österlund and Gabriel Fried1

Reproductive Medical Center, Division of Obstetrics and Gynecology, Department of Women and Child Health, Karolinska Hospital, S-171 76 Stockholm, Sweden

Abstract

We have recently found that values of the transforming growth factor (TGF)ß1 in human ovarian follicular fluid obtained during ovarian stimulation for IVF were higher in women who subsequently became pregnant following embryo transfer. We therefore postulated that TGFß1 may have a beneficial effect on the preimplantation embryo and improve the chances of a successful implantation. We have used reverse transcription–polymerase chain reaction (RT–PCR) and immunohistochemistry to investigate the presence in human oocytes and preimplantation embryos of the essential components of the TGFß signalling pathway, TGFß receptors type I and II and the substrate proteins Smad 2 and 3. We found that both receptors, as well as Smad 2 and 3, were present in the unfertilized oocyte, whereas only the type I receptor and Smad 2 and 3 were present at the blastocyst stage. At the 4-cell and 8-cell stages neither of the receptors was present, but Smad 2 and 3 were present at both stages. These findings support our hypothesis that the TGFß1 in follicular fluid may interact with the oocyte and preimplantation embryo via TGFß receptors, and that TGFß signalling may be important for the development of the oocyte and the preimplantation embryo.

IVF/oocyte/signal transduction/Smad/TGFß

Notes

1 To whom correspondence should be addressed at: Division of Obstetrics and Gynecology, Reproductive Medical Center, Department of Woman and Child Health, Karolinska Hospital, S-171 76 Stockholm, Sweden. E-mail: gabriel.fried{at}fyfa.ki.se


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ReproductionHome page
R. L Jones, C. Stoikos, J. K Findlay, and L. A Salamonsen
TGF-{beta} superfamily expression and actions in the endometrium and placenta.
Reproduction, August 1, 2006; 132(2): 217 - 232.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. V. Ingman, R. L. Robker, K. Woittiez, and S. A. Robertson
Null Mutation in Transforming Growth Factor {beta}1 Disrupts Ovarian Function and Causes Oocyte Incompetence and Early Embryo Arrest
Endocrinology, February 1, 2006; 147(2): 835 - 845.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
H.Z. Li, X. Sun, A. Stavreus-Evers, and K. Gemzell-Danielsson
Effect of mifepristone on the expression of cytokines in the human Fallopian tube
Mol. Hum. Reprod., July 1, 2004; 10(7): 489 - 493.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
X. Gueripel, M. Benahmed, and A. Gougeon
Sequential Gonadotropin Treatment of Immature Mice Leads to Amplification of Transforming Growth Factor {beta} Action, Via Upregulation of Receptor-Type 1, Smad 2 and 4, and Downregulation of Smad 6
Biol Reprod, March 1, 2004; 70(3): 640 - 648.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y. Wang and W. Ge
Spatial Expression Patterns of Activin and Its Signaling System in the Zebrafish Ovarian Follicle: Evidence for Paracrine Action of Activin on the Oocytes
Biol Reprod, December 1, 2003; 69(6): 1998 - 2006.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. Pangas, A. W. Rademaker, D. A. Fishman, and T. K. Woodruff
Localization of the Activin Signal Transduction Components in Normal Human Ovarian Follicles: Implications for Autocrine and Paracrine Signaling in the Ovary
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2644 - 2657.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. Xu, J. Oakley, and E. A. McGee
Stage-Specific Expression of Smad2 and Smad3 During Folliculogenesis
Biol Reprod, June 1, 2002; 66(6): 1571 - 1578.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. E. Drummond, M. T. Le, J.-F. Ethier, M. Dyson, and J. K. Findlay
Expression and Localization of Activin Receptors, Smads, and {beta}glycan to the Postnatal Rat Ovary
Endocrinology, April 1, 2002; 143(4): 1423 - 1433.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. Tomic, S.G. Brodie, C. Deng, R.J. Hickey, J.K. Babus, L.H. Malkas, and J.A. Flaws
Smad 3 May Regulate Follicular Growth in the Mouse Ovary
Biol Reprod, April 1, 2002; 66(4): 917 - 923.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
J. F.C. Chow, K.-F. Lee, S. T.H. Chan, and W. S.B. Yeung
Quantification of transforming growth factor {beta}1 (TGF{beta}1) mRNA expression in mouse preimplantation embryos and determination of TGF{beta} receptor (type I and type II) expression in mouse embryos and reproductive tract
Mol. Hum. Reprod., November 1, 2001; 7(11): 1047 - 1056.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.